ALC:SWX
Alcon AG
58,22 CHF
arrow_upward
+0,48%(+0,28) 1K
30-apr, 17:31:54 (GMT+2) · CHF
search
Barcha belgilar
1K
5K
1O
6O
YBB
1Y
5Y
MAKS
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoALC tikeri uchun statistika yaratilmoqda...
Ochish
57,34 CHF
Yuqori
58,22 CHF
Past
56,92 CHF
Bozor kapitali
29,16 mlrd
Oʻrtacha hajm
914,43 ming
Hajmi
1,47 mln
Dividend
0,48%
Choraklik dividendlar
0,07 CHF
Eks-dividend sanasi
5-may, 2026
P/E koeffitsiyenti
37,27
52 haftalik eng yuqori
81,92 CHF
52 haftalik eng past
56,44 CHF
Aksiya boʻyicha daromad
1,56 CHF
Muomaladagi aksiyalar
499,70 mln
Xodimlar soni
26 ming
Yangiliklar
Internetdagi manbalardan
Stock Titan
·
11 soat oldin
Alcon shareholders approve CHF 0.28 dividend, add Scott Herren
Newser
·
2 hafta oldin
Why is Alcon (ALC) Stock outperforming recently | Price at $79.03, Up 1.31% - Social Buzz
Newser
·
3 hafta oldin
What support levels matter for Alcon (ALC) Stock | ALC: Q4 2025 Earnings: Alcon Inc. Ordinary Shares reports slight EPS miss - Shared Trade Ideas
Newser
·
3 hafta oldin
Is Alcon (ALC) Stock Near a Bottom | Price at $74.54, Down 0.03% - Insider Info
Profil
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
Alcon AG haqida
CEODavid J. Endicott
Xodimlar soni25,9 ming
Asos solingan1945
Bosh ofislarJeneva, Geneva, Shveytsariya
Sektor-
Veb-saytalcon.com
AI kontentda xatolar boʻlishi mumkin. Batafsil